For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.
Price · 1Y
$141.54
Thesis
Novanta supplies precision motion, photonics, and vision subsystems that get designed into automation equipment, medical robots, and advanced industrial machines. It's a picks-and-shovels enabler — the customer builds the robot or instrument, Novanta provides the high-spec motion control, laser/beam delivery, or machine-vision engine inside it — which gives it sticky, sole-source content across many platforms.
The case is a high-quality, profitable component compounder with exposure to both factory automation and medical robotics. Growth is steady rather than explosive, and it tracks the broader capital-equipment and medical-device cycles; the watch items are end-market demand and integration of its serial acquisitions.
Catalysts
- Automation and medical-robotics design wins
- Machine-vision and photonics content growth
- Capital-equipment demand recovery
- Margin and free-cash-flow trajectory
Recent events
Material filings, federal awards, and regulatory activity. Impact is scored against market cap.
- Jun 29Securities offeringSEC
Novanta Inc. filed Form S-3ASR automatic shelf registration statement.
- Jun 9OtherSEC
8-K filing (items 1.01, 7.01, 9.01) disclosing entry into a material definitive agreement.
- Jun 9Securities offeringSEC
8-K filing (items 1.01, 3.02, 8.01, 9.01) disclosing material agreement and unregistered equity securities sale.